Both tumor and stromal cells have been shown to express IL-33, ST2L, and sST2 thus IL-33/ST2 signaling can potentially function in an autocrine or paracrine fashion to stimulate tumor cells as well as stromal cells in the TME. The gene discussed is IL1RL1; the disease is neoplasm.